This Year In Medicine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from This year in medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In This Year In Medicine Today - Breaking & Trending Today

Keeping an Eye Out: Safety Recalls Impact Over-the-Counter Eye Drops

Reports of eye infection and enucleation related to OTC eye drops concerned the eye care community in 2023 and drove increased vigilance towards ensuring safer ophthalmic products. ....

United States , Andrew Jassy , Timothy Janetos , Veeral Sheth , Hani Salehi , Kilitch Healthcare India , Drug Administration , Global Pharma Healthcare Private , Centers For Disease , University Retina , Health Alert Network Advisory , Northwestern University Feinberg School Of Medicine , Rite Aid , Retina Associates Of Southern California , Disease Control , Northwestern University Feinberg School , Current Good Manufacturing Practice , Adverse Event Reporting System , Ezricare Artificial Tears , Delsam Pharma , Artificial Tears , Global Pharma Healthcare Private Limited , Global Pharma , Global Pharma Healthcare , Velocity Pharma , Kilitch Healthcare India Limited ,

Advancing Lupus Care: The Changing Landscape of Treatment

The progression toward more targeted, disease-modifying options for the historically difficult rheumatic disease made more headway in 2023. ....

United States , Aprilm Jorge , Brad Rovin , Jack Arnold , Rosalind Ramsey Goldman , Chris Wincup , European Alliance Of Associations , Ohio State University Wexner Medical Center , Drug Administration , King College Hospital Lupus Unit , Leeds Centre Of Rheumatic , College Hospital Lupus Unit , Research Professor , Northwestern University Feinberg School , Leeds Centre , Massachusetts General Hospital , New England Journal , Tyrosine Kinase , Lupus Low Disease Activity State , Ann Rheum , European Medical , Belimumab After Rituximab , Systemic Lupus Erythematosus , Randomized Controlled , Ann Intern , Active Systemic Lupus ,

Keeping A Watchful Eye: Safety Reports in Geographic Atrophy Landscape

A headline year for retina disease drug development concurrently brought about research and discussion into the safety outcomes of these new agents. ....

United States , San Francisco , Iapocec Apellis , David Lally , Kunzmannk Apellis , Dilsher Dhoot , Veeral Sheth , Iapocec Charles Wykoff , Charles Wykoff , Nathan Steinle , Avacincaptad Pegol , Iapocec Pegcetacoplan , Iapocec Nathan Steinle , University Retina , Apellis Pharmaceuticals , Macula Associates , Drug Administration , American Society Of Retina Specialists , Apellis Pharmaceuticals Inc , American Academy Of Ophthalmology , Retina Consultants , New England Retina Consultants , American Society , Retina Specialists , Annual Meeting , California Retina Consultants ,

Multidrug Resistant Infections: Is the Clinical Infection Treatment Pathway Outdated?

The current treatment paradigm might need to evolve to adjust to rapid diagnostics and narrowing down the antibiotics to aid in optimal outcomes for sicker patients with gram-negative infections. ....

United States , New York , Albany College Of Pharmacy , Rodneye Rohde , Sameers Kadri , Tom Lodise , American Society For Clinical Laboratory Science , Critical Care Medicine Department , Texas State University , National Institutes Of Health Clinical Center , Centers For Disease , Cystic Fibrosis Foundation , Health Sciences , Partnership To Fight Infectious Disease , Biotechnology Innovation Organization , Clinical Laboratory Science , Stratton Va Medical Center , Clinical Laboratory Workforce Shortage , Albany College , Disease Control , American Society , Clinical Epidemiology Section , National Institutes , Health Clinical Center , Pasteur Act , Fight Infectious Disease ,

The Lupus Approach: CAR-T Begins the Jump from Blood Cancers to Autoimmune Disease

Throughout 2023, interest in the application of CAR-T and other cell therapies to autoimmune disease skyrocketed, with a multitude of clinical trials being initiated by various companies. ....

United States , David Porter , Tiffany Chen , Petera Merkel , Artiva Biotherapeutics , Davidj Chang , Artiva Biotherapeutic Allo , Tom Van Blarcom , Nkarta Inc , Artiva Biotherapeutics Inc , Immpact Bio United States Inc , Cabaletta Bio Inc , Gracell Biotechnologies Inc , Division Of Rheumatology , Kyverna Therapeutics , Cabaletta Bio , Gracell Biotechnologie , Cell Therapy , Autoimmune Disease Summit , Penn Medicine , Van Blarcom , Gene Therapy , Blood Cancer , Autoimmune Disease , Car T , This Year In Medicine ,